+13.1%
GSK vs BBWI
+2.4%
+10.7%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BBWI | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +4.1% | +0.9% | +4.7% |
| 7D | +4.9% | +8.8% | -3.8% | +4.2% |
| 30D | +9.9% | +34.8% | -24.9% | +7.5% |
| 3M | +0.2% | +12.9% | -12.8% | -0.8% |
| 6M | +2.3% | +29.6% | -27.3% | +0.1% |
| YTD | +7.1% | +20.8% | -13.7% | +5.2% |
| 1Y | +13.1% | +4.1% | +9.0% | +11.0% |
| All | +13.1% | +2.4% | +10.7% | +11.0% |
Cumulative growth
Daily Returns
Daily percentage return beside BBWI.
Daily Out/Under-Performance
Portfolio return minus BBWI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBWI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BBWI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling